Discover how in-process testing strengthens quality control at Xellera Therapeutics. Through real-time monitoring and data-driven insights, it reduces variability, enhances consistency, and supports Quality by Design (QbD)—ensuring reliable, safe, and scalable manufacturing of advanced cell and gene therapies in regulated cGMP environments. https://ext-6783855.livejournal.com/267.html